论文信息 - 624PDA phase III trial of muparfostat (PI-88) as adjuvant therapy in patients with hepatitis virus related hepatocellular carcinoma (HV-HCC) after resection - 字舞流文

624PDA phase III trial of muparfostat (PI-88) as adjuvant therapy in patients with hepatitis virus related hepatocellular carcinoma (HV-HCC) after resection

L. Jeng | M. Ho | Y. Mao | P. Chen | Huifen Wang | T. Cheung | W-C Lee | G. Chau | R. Hu | P. Lee | J. Y. Choi | C-L Chen | K. Han | Kuan-Lang Lai | M. Cho | J. Fan | K. S. Lee | F-C Hu | S. Paik | C. Wu